Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

Both companies will focus on technology integration and marketing to ensure the successful adoption of the integrated solution.

Single-atom editing under mild conditions was achieved for heterocyclics, thanks to a new oxygen-to-nitrogen photocatalyst.

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...

The company claims to have decoded human cell rejuvenation and identified potential gene targets for therapies that treat ...

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...

Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for ...

Illumina unveiled its MiSeq i100 Series of sequencing systems: two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus ...

Researchers suggest findings could help to pinpoint cell types most vulnerable to conditions such as schizophrenia, and ...

Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially ...

The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next ...

Newly launched Judo Bio aims to develop ligand-siRNA conjugates through its Selectively Targeting RNA Into KidnEy (STRIKE) ...